Ballast Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Ballast Advisors's AMGN Position: Q1 2026 in Review
Ballast Advisors reduced its Amgen (AMGN) stake by 2% in Q1 2026, selling an estimated $9.63K and leaving 1,297 shares worth $456K. The position accounts for 0.13% of the portfolio, ranked #74.
Ballast Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $483K in Q4 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Ballast Advisors held 1,297 shares of Amgen worth $456K as of Q1 2026.
- Ballast Advisors sold 27 Amgen shares in Q1 2026, an estimated $9.63K.
- Amgen made up 0.13% of Ballast Advisors's portfolio in Q1 2026, its #74 holding.
- Ballast Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- Ballast Advisors's Amgen position peaked at $483K in Q4 2022.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Ballast Advisors's 13F filing for Q1 2026, filed 13 May 2026.